Recently, the EXTEND trial assessed the effectiveness of IV tPA initiated 4.5 to 9.0 h after stroke onset in patients with a favorable perfusion-imaging profile detected by automated perfusion imaging (38). The gene discussed is PLAT; the disease is Stroke.